<div id="readability-page-1"><div><p>As global markets experience a resurgence in investor confidence following the U.S.-Iran ceasefire agreement, small-cap stocks have shown resilience, with indices like the S&amp;P MidCap 400 and Russell 2000 posting notable gains. In this environment of improved sentiment and easing geopolitical tensions, investors often look for small-cap opportunities that demonstrate strong fundamentals and insider buying as potential indicators of value.</p><h3>Top 10 Undervalued Small Caps With Insider Buying Globally</h3><div><table><tbody><tr><th>Name</th><th>PE</th><th>PS</th><th>Discount to Fair Value</th><th>Value Rating</th></tr><tr><td>CellaVision</td><td>23.5x</td><td>4.7x</td><td>42.37%</td><td>★★★★★★</td></tr><tr><td>Eurocell</td><td>11.6x</td><td>0.3x</td><td>45.49%</td><td>★★★★★☆</td></tr><tr><td>PSC</td><td>10.7x</td><td>0.5x</td><td>47.79%</td><td>★★★★☆☆</td></tr><tr><td>Nexus Industrial REIT</td><td>9.5x</td><td>3.3x</td><td>5.60%</td><td>★★★★☆☆</td></tr><tr><td>ASL Marine Holdings</td><td>10.7x</td><td>0.9x</td><td>-41.78%</td><td>★★★☆☆☆</td></tr><tr><td>Bilia</td><td>15.7x</td><td>0.3x</td><td>17.17%</td><td>★★★☆☆☆</td></tr><tr><td>Nickel Asia</td><td>10.7x</td><td>2.3x</td><td>14.27%</td><td>★★★☆☆☆</td></tr><tr><td>Shoucheng Holdings</td><td>44.2x</td><td>9.5x</td><td>42.81%</td><td>★★★☆☆☆</td></tr><tr><td>Centurion</td><td>12.2x</td><td>4.2x</td><td>-20.53%</td><td>★★★☆☆☆</td></tr><tr><td>SiteMinder</td><td>NA</td><td>3.3x</td><td>48.93%</td><td>★★★☆☆☆</td></tr></tbody></table></div><p> Click here to see the full list of 170 stocks from our Undervalued Global Small Caps With Insider Buying screener.     </p><p>Let's review some notable picks from our screened stocks.</p><h2>Eastnine (OM:EAST)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Eastnine is a real estate company focusing on property investments in the Baltic region and Poland, with a market capitalization of €0.23 billion.</p><p><strong>Operations:</strong> Revenue is primarily generated from properties in Vilnius, Warsaw, Poznan, and Riga. The company has shown a gross profit margin of 93.39% as of December 2025. Operating expenses include general and administrative costs along with sales and marketing expenses.</p><p><strong>PE:</strong> 10.1x</p><p>Eastnine, a smaller company with potential, recently reported a significant turnaround in financial performance. Sales for the fourth quarter reached €15.43 million, up from €12.41 million the previous year, and net income improved to €4.4 million from a net loss of €0.24 million. Insider confidence is evident as an individual purchased 155,000 shares valued at approximately SEK 6.98 million in March 2026, indicating belief in future prospects despite earnings forecasted to decline by 4% annually over the next three years due to high-risk funding sources and interest coverage concerns.</p><ul><li>Get an in-depth perspective on Eastnine's performance by reading our valuation report here.</li><li>Assess Eastnine's past performance with our detailed historical performance reports.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fa47a548-7857-4339-9f80-78dea555c5dc/chart/dcf?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fa47a548-7857-4339-9f80-78dea555c5dc/chart/dcf?"/><figcaption>OM:EAST Share price vs Value as at Apr 2026</figcaption></figure><h2>MedCap (OM:MCAP)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★☆☆☆</p><p><strong>Overview:</strong> MedCap is a company involved in assistive technology, medical technology, and specialty medication with a market cap of SEK 5.18 billion.</p><p><strong>Operations:</strong> MedCap generates revenue from three main segments: Assistive Tech, Medical Technology, and Specialty Medication. The company has seen fluctuations in its gross profit margin, reaching 61.38% in December 2021 before experiencing some variability in subsequent periods. Operating expenses are a significant component of the cost structure, with general and administrative expenses consistently forming a substantial portion of these costs.</p><p><strong>PE:</strong> 33.3x</p><p>MedCap's revenue and net income have shown significant growth, with fourth-quarter sales reaching SEK 591 million, up from SEK 474.2 million the previous year. This financial performance is complemented by insider confidence, demonstrated through share purchases over the past year. Despite relying on higher-risk external borrowing for funding, MedCap's earnings are projected to grow annually by 15.11%. These factors suggest potential for value appreciation in the healthcare sector amidst ongoing industry developments.</p><ul><li>Dive into the specifics of MedCap here with our thorough valuation report.</li><li>Review our historical performance report to gain insights into MedCap's's past performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/223b2cee-0461-4325-9caa-5336a1f2738d/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/223b2cee-0461-4325-9caa-5336a1f2738d/chart/ownership-breakdown?"/><figcaption>OM:MCAP Ownership Breakdown as at Apr 2026</figcaption></figure><h2>MCAN Mortgage (TSX:MKP)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★☆☆☆</p><p><strong>Overview:</strong> MCAN Mortgage is a Canadian company that primarily operates in the financial services sector, focusing on mortgage lending, with a market capitalization of approximately CA$0.54 billion.</p><p><strong>Operations:</strong> MCAN Mortgage generates revenue primarily from its financial services in the mortgage sector, with a recent gross profit margin of 100%. Operating expenses have shown variability, reaching CA$59.18 million in the latest period.</p><p><strong>PE:</strong> 13.0x</p><p>MCAN Mortgage, a smaller company in the financial sector, recently reported net income of C$74.87 million for 2025, slightly down from the previous year. Despite this dip, they increased their first-quarter dividend by 5% to C$0.43 per share, reflecting confidence in future prospects. Leadership changes include new appointments like a Chief Risk Officer and Chief People Officer to strengthen governance and align strategy with growth objectives. Earnings are forecasted to grow annually by 16%.</p><ul><li>Unlock comprehensive insights into our analysis of MCAN Mortgage stock in this valuation report.</li><li>Evaluate MCAN Mortgage's historical performance by accessing our past performance report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/33ac0d10-1695-4d24-b25c-23ca2618d8d4/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/33ac0d10-1695-4d24-b25c-23ca2618d8d4/chart/ownership-breakdown?"/><figcaption>TSX:MKP Ownership Breakdown as at Apr 2026</figcaption></figure><h2>Make It Happen</h2><ul><li>Gain an insight into the universe of 170 Undervalued Global Small Caps With Insider Buying by clicking here.</li><li>Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.</li><li>Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.</li></ul><h2>Looking For Alternative Opportunities?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

MIDE

VTWG

<p>As global markets recover post-U.S.-Iran ceasefire, small-cap stocks like S&P MidCap 400 and Russell 2000 gain traction. Investors are eyeing undervalued small caps with insider buying as indicators of potential value. Notable picks include Eastnine, MedCap, and MCAN Mortgage, each showing strong fundamentals and insider confidence despite some financial challenges. Eastnine reported a turnaround in performance, MedCap's revenue growth is promising, and MCAN Mortgage increased dividends, reflecting optimism. The article highlights 170 undervalued global small caps for investors to consider.</p>

Global's Top 3 Undervalued Small Caps With Insider Buying To Consider